NDC 52959-539

CELEBREX

Celecoxib

CELEBREX is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Celecoxib.

Product ID52959-539_fa8f4605-2a86-49f2-8a42-d706ce01a5b0
NDC52959-539
Product TypeHuman Prescription Drug
Proprietary NameCELEBREX
Generic NameCelecoxib
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1998-10-02
Marketing CategoryNDA / NDA
Application NumberNDA020998
Labeler NameH.J. Harkins Company, Inc.
Substance NameCELECOXIB
Active Ingredient Strength200 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 52959-539-00

100 CAPSULE in 1 BOTTLE (52959-539-00)
Marketing Start Date1998-10-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52959-539-20 [52959053920]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-00 [52959053900]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-15 [52959053915]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-30 [52959053930]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-05 [52959053905]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-14 [52959053914]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-10 [52959053910]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-21 [52959053921]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-07 [52959053907]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-45 [52959053945]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-28 [52959053928]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

NDC 52959-539-40 [52959053940]

CELEBREX CAPSULE
Marketing CategoryNDA
Application NumberNDA020998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-10-02
Inactivation Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
CELECOXIB200 mg/1

OpenFDA Data

SPL SET ID:b6bd0101-ebf0-43e8-99bf-21cb032b05d6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213468
  • 213469
  • 205322
  • 205323
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
    • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721

    • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    NDC Crossover Matching brand name "CELEBREX" or generic name "Celecoxib"

    NDCBrand NameGeneric Name
    0025-1515CELEBREXCelecoxib
    0025-1520CELEBREXCelecoxib
    0025-1525CELEBREXCelecoxib
    0025-1530CELEBREXCelecoxib
    68387-552CELEBREXCELEBREX
    68788-0768CELEBREXCELEBREX
    21695-023CELEBREXCELEBREX
    21695-022CELEBREXCELEBREX
    33261-019CELEBREXCELEBREX
    49999-383CELEBREXCELEBREX
    52959-540CELEBREXCELEBREX
    52959-539CELEBREXCELEBREX
    55154-3621CELEBREXCELEBREX
    55154-3622CELEBREXCELEBREX
    55289-451CELEBREXCELEBREX
    55154-3625CELEBREXCELEBREX
    55289-475CELEBREXCELEBREX
    61919-046CELEBREXCELEBREX
    63187-079CELEBREXCELEBREX
    63629-6368CELEBREXCELEBREX
    63629-3021CELEBREXCELEBREX
    66336-940CELEBREXCELEBREX
    67544-204CELEBREXCELEBREX
    80425-0096CelebrexCelebrex
    80425-0038CelebrexCelebrex
    80425-0040CelebrexCelebrex
    80425-0037CelebrexCelebrex
    80425-0039CelebrexCelebrex
    0093-7165CelecoxibCelecoxib
    0093-7166CelecoxibCelecoxib
    0093-7170CelecoxibCelecoxib
    0093-7306CelecoxibCelecoxib

    Trademark Results [CELEBREX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CELEBREX
    CELEBREX
    88814821 not registered Live/Pending
    G. D. Searle LLC
    2020-02-28
    CELEBREX
    CELEBREX
    75655826 2321622 Live/Registered
    G. D. SEARLE LLC
    1999-03-08
    CELEBREX
    CELEBREX
    75432043 2307888 Live/Registered
    G. D. SEARLE LLC
    1998-02-10
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.